An FDA panel is currently reviewing the possibility of easing restrictions on peptides, which could lead to a clash between FDA scientists and Robert F. Kennedy Jr.'s agenda.

FDA scientists have flagged concerns regarding peptides, trendy molecules supported by RFK Jr., citing a lack of good evidence for their efficacy or safety ahead of an FDA panel meeting.

FDA scientists have issued warnings that some popular peptides are ineffective and potentially dangerous, leading to criticism of figures like RFK Jr. for promoting unproven health claims.